Safe and successful CAR T-cell therapy targeting BCMA in a multiple myeloma patient requiring hemodialysis

被引：0
|
作者：
Ralph Wäsch
Tim Strüssmann
Claudia Wehr
Reinhard Marks
Phillip T. Meyer
Gerd Walz
Monika Engelhardt
机构：
[1] University of Freiburg,Department of Hematology, Oncology and Stem Cell Transplantation, Medical Center
[2] University of Freiburg, University of Freiburg, Faculty of Medicine
[3] University of Freiburg,Department of Nuclear Medicine, Medical Center
来源：
Annals of Hematology | 2023年 / 102卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1269 / 1270
页数：1
相关论文
共 50 条
  • [41] Cilta-cel, a BCMA-targeting CAR-T therapy for patients with multiple myeloma
    Jagannath, Sundar
    Jackson, Carolyn C.
    Schecter, Jordan M.
    Lendvai, Nikoletta
    Sun, Huabin
    Akram, Muhammad
    Patel, Nitin
    Martin, Thomas G.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (05) : 339 - 350
  • [42] Impact of soluble BCMA and non-T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myeloma
    Lee, Holly
    Durante, Michael
    Skerget, Sheri
    Vishwamitra, Deeksha
    Benaoudia, Sacha
    Ahn, Sungwoo
    Poorebrahim, Mansour
    Barakat, Elie
    Jung, David
    Leblay, Noemie
    Ziccheddu, Bachisio
    Diamond, Benjamin
    Papadimitriou, Marios
    Cohen, Adam D.
    Landgren, Ola
    Neri, Paola
    Maura, Francesco
    Bahlis, Nizar J.
    BLOOD, 2024, 144 (25) : 2637 - 2651
  • [43] Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma
    Liang, Zhiyu
    Li, Ping
    Kang, Liqing
    Zhou, Lili
    Xu, Yang
    Ye, Shiguang
    Du, Juan
    Li, Bing
    Wang, Yiwen
    Yu, Lei
    Qian, Wenbin
    Liang, Aibin
    BLOOD ADVANCES, 2022, 6 (01) : 293 - 296
  • [44] Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma
    Wang, Ying
    Li, Chunrui
    Xia, Jieyun
    Li, Ping
    Cao, Jiang
    Pan, Bin
    Tan, Xu
    Li, Hujun
    Qi, Kunming
    Wang, Xiangmin
    Shi, Ming
    Jing, Guangjun
    Yan, Zhiling
    Cheng, Hai
    Zhu, Feng
    Sun, Haiying
    Sang, Wei
    Li, Depeng
    Zhang, Xi
    Li, Zhenyu
    Zheng, Junnian
    Liang, Aibin
    Zhou, Jianfeng
    Xu, Kailin
    BLOOD ADVANCES, 2021, 5 (23) : 5290 - 5299
  • [45] Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma
    Reyes, Kevin R.
    Huang, Chiung-Yu
    Lo, Mimi
    Arora, Shagun
    Chung, Alfred
    Wong, Sandy W.
    Wolf, Jeffrey
    Olin, Rebecca L.
    Martin, Thomas
    Shah, Nina
    Banerjee, Rahul
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (06): : 350 - 355
  • [46] Ciltacabtagene autoleucel CAR-T therapy targeting B-cell maturation antigen (BCMA) Treatment of multiple myeloma
    Lee, Sarah
    Cowan, Andrew J.
    DRUGS OF THE FUTURE, 2022, 47 (04) : 233 - 238
  • [47] BCMA CAR-T therapy combined with pomalidomide is a safe and effective treatment for relapsed/refractory multiple myeloma
    Yan, Yuhan
    Tu, Yixuan
    Cheng, Qian
    Zhang, Jian
    Wang, Erhua
    Deng, Zuqun
    Yu, Yan
    Wang, Liwen
    Liu, Rui
    Chu, Ling
    Kang, Liqing
    Liu, Jing
    Li, Xin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [48] CAR T-cell therapy in multiple myeloma: more room for improvement
    Teoh, Phaik Ju
    Chng, Wee Joo
    BLOOD CANCER JOURNAL, 2021, 11 (04)
  • [49] CAR T-cell therapy for multiple myeloma: state of the art and prospects
    van de Donk, Niels W. C. J.
    Usmani, Saad Z.
    Yong, Kwee
    LANCET HAEMATOLOGY, 2021, 8 (06): : E446 - E461
  • [50] CAR T-cell therapy in multiple myeloma: more room for improvement
    Phaik Ju Teoh
    Wee Joo Chng
    Blood Cancer Journal, 11
12345